Quotables
"The man with a new idea is a crank until the idea succeeds."
Samuel Clemens
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7119118 | Highly purified ethyl EPA and other EPA derivatives for treatment of huntington's disease A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form of EPA and where less than 5%, and preferably less than 3%, is in the f... | 10/10/2006 |
| 6919330 | Formulations of drugs The treatment of psychiatric or neurological disorders using selenium in combination with drugs used conventionally to treat such disorders is disclosed. The daily dose of selenium is between 10 μg and 2000 μg per day. ... | 07/19/2005 |
| 6689812 | Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form of EPA and where less than 5%, and preferably less than 3%, ... | 02/10/2004 |
| 6479544 | Therapeutic combinations of fatty acids Eicosapentaenoic acid or any appropriate derivative (EPA) is disclosed in combination with arachidonic acid (AA) or an AA precursor, selected from DGLA and GLA, to give a pharmaceutical formulation.... | 11/12/2002 |
| 6441038 | Treatment of fatigue, head injury and stroke A method of treatment of disorders of neurological origin and drug formulations for use in the method are disclosed. These conditions comprise fatigue and associated syndromes of pain, weakness and depressed mood which are associated with chronic fatigue ... | 08/27/2002 |
| 6384077 | Highly purified EPA for treatment of schizophrenia and related disorders A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form of EPA and where less than 5%, and preferably less than 3%, ... | 05/07/2002 |
